Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $9.0200 (-2.38%) ($9.0100 - $9.0200) on Fri. Mar. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.74% (three month average) | RSI | 22 | Latest Price | $9.0200(-2.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.6% a day on average for past five trading days. | Weekly Trend | ATRA declines -17.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(50%) ARKK(47%) IBB(47%) ARKG(46%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -2.37% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-18%) EDOC(-13%) USO(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.37% (StdDev 4.74%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-23.55(-361.09%) | Resistance Level | $11.55 | 5 Day Moving Average | $9.03(-0.11%) | 10 Day Moving Average | $9.56(-5.65%) | 20 Day Moving Average | $11.55(-21.9%) | To recent high | -47.9% | To recent low | 5.1% | Market Cap | $670m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |